FI912879A0 - Menetelmä plasmaperäisen C3b-inaktivaattoriliuoksen valmistamiseksi, joka ei sisällä oleellisesti tekijä B-aktiivisuutta eikä infektoivan viruksen aktiivisuutta - Google Patents

Menetelmä plasmaperäisen C3b-inaktivaattoriliuoksen valmistamiseksi, joka ei sisällä oleellisesti tekijä B-aktiivisuutta eikä infektoivan viruksen aktiivisuutta

Info

Publication number
FI912879A0
FI912879A0 FI912879A FI912879A FI912879A0 FI 912879 A0 FI912879 A0 FI 912879A0 FI 912879 A FI912879 A FI 912879A FI 912879 A FI912879 A FI 912879A FI 912879 A0 FI912879 A0 FI 912879A0
Authority
FI
Finland
Prior art keywords
factor
activity
plasma
derived
essentially free
Prior art date
Application number
FI912879A
Other languages
English (en)
Swedish (sv)
Other versions
FI95440C (fi
FI95440B (fi
Inventor
Karina Oestergaard Alsoe
Jesper Kihl
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI912879A0 publication Critical patent/FI912879A0/fi
Application granted granted Critical
Publication of FI95440B publication Critical patent/FI95440B/fi
Publication of FI95440C publication Critical patent/FI95440C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI912879A 1988-12-20 1991-06-14 Menetelmä plasmaperäisen C3b-inaktivaattoriliuoksen valmistamiseksi, joka ei sisällä oleellisesti tekijä B-aktiivisuutta eikä infektoivan viruksen aktiivisuutta FI95440C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
DK708488 1988-12-20
PCT/DK1989/000297 WO1990006759A1 (en) 1988-12-20 1989-12-19 A pure factor i protein and a process for producing said protein
DK8900297 1989-12-19

Publications (3)

Publication Number Publication Date
FI912879A0 true FI912879A0 (fi) 1991-06-14
FI95440B FI95440B (fi) 1995-10-31
FI95440C FI95440C (fi) 1996-02-12

Family

ID=8149208

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912879A FI95440C (fi) 1988-12-20 1991-06-14 Menetelmä plasmaperäisen C3b-inaktivaattoriliuoksen valmistamiseksi, joka ei sisällä oleellisesti tekijä B-aktiivisuutta eikä infektoivan viruksen aktiivisuutta

Country Status (11)

Country Link
US (1) US5378811A (fi)
EP (1) EP0449897B1 (fi)
JP (1) JPH04502324A (fi)
AT (1) ATE101521T1 (fi)
AU (1) AU4811290A (fi)
DE (1) DE68913212T2 (fi)
DK (2) DK708488D0 (fi)
ES (1) ES2062502T3 (fi)
FI (1) FI95440C (fi)
NO (1) NO912387L (fi)
WO (1) WO1990006759A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
EP1107807B1 (en) * 1998-08-25 2006-10-11 Ash Access Technology, Inc. Use of citrate in a catheter lock solution
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
GB0904427D0 (en) 2009-03-13 2009-04-29 Lachmann Peter Treatment of diseases related to hyperactivity of the complement system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤

Also Published As

Publication number Publication date
DK105391A (da) 1991-06-03
WO1990006759A1 (en) 1990-06-28
NO912387D0 (no) 1991-06-19
AU4811290A (en) 1990-07-10
DE68913212D1 (de) 1994-03-24
DE68913212T2 (de) 1994-05-19
NO912387L (no) 1991-06-19
EP0449897A1 (en) 1991-10-09
ES2062502T3 (es) 1994-12-16
ATE101521T1 (de) 1994-03-15
FI95440C (fi) 1996-02-12
DK105391D0 (da) 1991-06-03
DK708488D0 (da) 1988-12-20
US5378811A (en) 1995-01-03
FI95440B (fi) 1995-10-31
EP0449897B1 (en) 1994-02-16
JPH04502324A (ja) 1992-04-23

Similar Documents

Publication Publication Date Title
GB2199328B (en) Use of a 5' untranslated leader sequence of an rna virus to enhance translation
BR9205640A (pt) Dímero de apolipoproteína ai-milano, composiçao farmacológica, processo de preparaçao do dímero, uso deste na preparaçao de medicamentos e processo para o tratamento de aterosclerose e doenças cardiovasculares
ATE162549T1 (de) Epitheline: neue cystein-reiche, den wachstum modulierende proteine
DE3787842D1 (de) Mittel zur Behandlung von Arthrosen.
FI98491B (fi) Menetelmä virusinaktivoidun verituotteen valmistamiseksi
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE3770184D1 (de) Behandlung von gasstroemen.
DK617086D0 (da) Antibiotikum a 40926 mannosyl-aglycon og additionssalte deraf samt laegemiddel indeholdende en saadan forbindelse
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
FI912879A0 (fi) Menetelmä plasmaperäisen C3b-inaktivaattoriliuoksen valmistamiseksi, joka ei sisällä oleellisesti tekijä B-aktiivisuutta eikä infektoivan viruksen aktiivisuutta
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
SE9001378D0 (sv) A method for the preparation of pyridoxylated hemoglobin
DE3672251D1 (de) Herstellung von cholecalciferolderivaten und neue hierfuer verwendete zwischenprodukte.
ATE97575T1 (de) Verwendung eines polypeptids mit interleukin 2aktivit|t zur herstellung einer zur behandlung von einfachen pleurageschwueren bestimmten pharmazeutischen zusammensetzung.
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE3577801D1 (de) Verfahren zur herstellung von praeparationen auf basis von blutgerinnungsfaktoren.
GR930300003T1 (en) Inhibitor of proliferation of endothelial cells.
FI881123A (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
DE3783122D1 (de) Verwendung von rekombiniertem menschlichem alpha-interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
Alsoe et al. Pure C3B inactivator and a process for producing said protein
Kole The bacteriology of burn wounds in childhood: E. Knapp. Zbl. Chir. 90: 1117, 1965
ES2015772A6 (es) Procedimiento e obtencion de nuevos derivados del 5-fluorouracilo, concretamente los n1-acil-sustituidos-n3-orto-toluil-5-fluorouracilo.
Gilbert Giant hemangioma with thrombocytopenia: Radioisotopic demonstration of platelet sequestration: Herbert E. Brizel and Giovanni Raccuglia. Blood 26: 751, 1965

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed